Nuformix plc (LON:NFX)
London · Delayed Price · Currency is GBP · Price in GBX 0.2660
+0.0010 (0.38%)
Mar 6, 2026, 4:22 PM GMT
Nuformix Market Cap
Nuformix has a market cap or net worth of 5.59 million as of March 6, 2026. Its market cap has increased by 272.13% in one year.
Market Cap
5.59M
Enterprise Value
5.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since October 16, 2017, Nuformix's market cap has decreased from 17.28M to 5.59M, a decrease of -67.64%. That is a compound annual growth rate of -12.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 5.59M | 3.92% |
| Dec 31, 2025 | 5.38M | 698.00% |
| Dec 31, 2024 | 674.17K | -72.13% |
| Dec 29, 2023 | 2.42M | 0.30% |
| Dec 30, 2022 | 2.41M | -63.56% |
| Dec 31, 2021 | 6.62M | -52.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 10.73M |
| Genflow Biosciences | 9.38M |
| Futura Medical | 7.28M |
| IXICO | 7.27M |
| CRISM Therapeutics | 6.21M |
| Cizzle Biotechnology Holdings | 5.95M |
| OptiBiotix Health | 5.94M |
| Theracryf | 4.41M |